Skip to content

Compare U.S. Stocks

Put up to three companies side by side on valuation, growth, profitability, and debt.

Compare within a sector
MetricBIIBBiogenMRNAModernaONCBeOne Medicines AG
Snapshot
Price$225.31$182.52$365.95
Market cap$31.91B$31.65B$33.43B
Valuation
P/E24.2x—71.9x
Forward P/E26.3x——
Growth
Revenue growth1.2%-30.0%36.2%
EPS growth-8.1%——
Profitability
Net margin13.8%-143.6%7.8%
ROE7.5%-36.7%5.2%
Balance sheet & cash
Debt / equity0.34x0.07x0.25x
Free cash flow yield6.8%-13.6%—
Dividend yield———
Verdict
Investment ratingNeutral· 49Weak· 17Neutral· 48

5-Year Price Projections

Base case

Projected using each stock's current EPS, growth rate (EPS or revenue growth), and P/E ratio. P/E assumed to compress 25% on the low end and remain steady on the high end. Not a forecast — for comparative analysis only.

YearBIIBtoday $225MRNAtoday $183ONCtoday $366
2027$172.36 – $252.80+12% CAGR$139.63 – $204.79+12% CAGR$373.76 – $548.19+50% CAGR
2028$175.81 – $257.85+7% CAGR$142.42 – $208.88+7% CAGR$508.99 – $746.52+43% CAGR
2029$179.33 – $263.01+5% CAGR$145.27 – $213.06+5% CAGR$693.14 – $1,016.61+41% CAGR
2030$182.91 – $268.27+4% CAGR$148.17 – $217.32+4% CAGR$943.92 – $1,384.42+39% CAGR
2031$186.57 – $273.64+4% CAGR$151.14 – $221.67+4% CAGR$1,285.43 – $1,885.30+39% CAGR
5-yr CAGR-3.7% – 4.0%-3.7% – 4.0%28.6% – 38.8%